BridgeMD
New treatment option for Hemifacial Microsomia
Official title Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction.
ClinicalTrials.gov ID: NCT07654647
What this study is testing
- What it's testing
- This clinical study aims to evaluate the effectiveness of patient-specific 3D-printed titanium facial implants in the reconstruction and aesthetic correction of facial defects. The study will include patients presenting with congenital, traumatic, or post-surgical facial deformities requiring reconstructive intervention.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Age 18 years or older.
- Presence of facial bone defects resulting from cystic or tumoral osteolytic lesions.
- Acquired or congenital facial deformities associated with bony defects or facial asymmetry.
- Patients requiring patient-specific 3D-printed titanium implants for maxillofacial reconstruction.
- Aesthetic indications requiring custom facial implant design, including microgenia (chin retrusion).
You likely can't join if
- Active pathological lesions at the time of enrollment.
- Age below 18 years.
- History of radiotherapy within 12 months prior to enrollment.
- Chronic untreated vitamin D deficiency.
- Uncontrolled diabetes mellitus.
- Inability or unwillingness to comply with follow-up requirements.
See the full eligibility criteria
- Age 18 years or older.
- Presence of facial bone defects resulting from cystic or tumoral osteolytic lesions.
- Acquired or congenital facial deformities associated with bony defects or facial asymmetry.
- Patients requiring patient-specific 3D-printed titanium implants for maxillofacial reconstruction.
- Aesthetic indications requiring custom facial implant design, including microgenia (chin retrusion).
- Ability to provide written informed consent.
- Active pathological lesions at the time of enrollment.
- Age below 18 years.
- History of radiotherapy within 12 months prior to enrollment.
- Chronic untreated vitamin D deficiency.
- Uncontrolled diabetes mellitus.
- Inability or unwillingness to comply with follow-up requirements.
The study team makes the final eligibility decision.
Where it's taking place
- Latakia, Syria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Latakia, Syria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.